Biotech startup panCELLa raises $1 mln in seed funding
Toronto biotechnology company panCELLa Inc has secured $1 million in a seed-stage financing. The investor was Chiefswood Holdings, a Canadian holding company. The proceeds of the round will be used to begin commercialization of panCELLa's "fail-safe" cell therapy, which is being developed to treat degenerative and malignant disorders, such as Alzheimer's disease and Parkinson's disease. Founded in 2015 by Dr. Andras Nagy and Dr. Armand Keating, panCELLa's technology platform is based on Dr. Nagy's work in the area of stem cell research.
24 January 2018•2 mins read
